Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)

Conditions

• Short Bowel Syndrome

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Liraglutide Pen Injector [Victoza] — DRUG
  Pilot study of liraglutide in patients with short bowel.

Study Details

Pilot study looking at the effect on Liraglutide in the reduction of parenteral support in patients with short bowel.

Key Dates

Start date

Oct 20, 2017

Status verified

Aug 2020

Primary completion

Aug 6, 2020

Completion

Sep 30, 2020

Study Design

Enrollment

0 participants (actual)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Arms

• Experimental: Test group

Primary Outcome Measure

Improvement in parenteral support [ Time Frame: 20 weeks post start of drug ]

Related Studies

• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
  Recruiting · Sanford Health · Sioux Falls, South Dakota
• A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
  Recruiting · Boston Children's Hospital · Boston, Massachusetts
• Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
  PHASE2 · Recruiting · Hanmi Pharmaceutical Company Limited · Boston, Massachusetts
• A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
  Recruiting · Eclipse Regenesis, Inc. · Palo Alto, California